Toes-Zoutendijk E. Interval cancers after a negative faecal immunochemical test in the first screening round in the Netherlands: results for two cut-off levels. UEG Week 2018, LB14.
LIBERTY fase III-trials: subcutane infliximab als onderhoudstherapie bij IBD
jan 2025 | IBD